Standalone Financial Results, Limited Review Report, Results Press Release for December 31, 2016
Novartis India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 20163. Result Press Release for the period ended December 31, 2016 Board Meeting Intimation for Results
Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 03, 2017, inter alia, to consider unaudited financial results of the Company for third quarter and nine months ended December 31, 2016. Shareholding for the Period Ended December 31, 2016
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Novartis India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Updates
Novartis India Ltd has submitted to BSE copies of notice for the attention of equity shareholders of the Company in respect of transfer of equity shares to Investor Education and Protection Fund (IEPF) Suspense Account published on December 23, 2016 in the newspapers in accordance with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. Standalone Financial Results, Limited Review Report, Results Press Release for September 30, 2016
Novartis India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 20163. Result Press Release for the period ended September 30, 2016 Board Meeting Intimation for Results
Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on November 11, 2016, inter alia, to consider unaudited financial results of the Company for the second quarter and half year ended September 30, 2016. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Novartis India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended September 30, 2016
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Shareholding for the Period Ended September 27, 2016
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 27, 2016. For more details, kindly Click here